For prostate cancer treatment, a nano-formulation designed for targeted SDT utilizes CTSB overexpression in the tumor microenvironment to enhance ultrasound-induced cytotoxicity, showing increased toxicity at acidic pH levels [235]. Here, CTSB is linked to neoplasm.